Left ventricular diastolic dysfunction and transmitral blood flow parameters in patients after COVID-19

Background. People who previously had COVID-19 infection have an increased risk of developing cardiovascular diseases. Left ventricular diastolic dysfunction is an early marker of the development of cardiac pathology. Its early detection is important for the adequate therapy order and dynamic monitoring of patients. In this regard, it seems relevant to study the effect of a recent COVID-19 infection on the left ventricular diastolic function and transmitral blood flow parameters in apparently healthy individuals without clinical and instrumental signs of cardiovascular pathology.

The aim of the study. To assess the changes in the diastolic and systolic function of  the left ventricle, its anatomical parameters and transmitral blood flow parameters in two groups of  apparently healthy individuals: those who had and those who had not COVID-19 infection.

Materials and methods. Transthoracic echocardiography was performed according to the standard technique and its results were analyzed in 66 examined patients who were recognized as apparently healthy according to the results of  regular comprehensive clinical and instrumental studies. The first group included 30 individuals who underwent an echocardiographic study before or during the COVID-19 pandemic, but did not have a coronavirus infection; the second group consisted of 36 people who recovered from COVID-19. The indicators of the presence of left ventricular diastolic dysfunction and the transmitral blood flow parameters were assessed. The study was approved at a meeting of the Medical Ethics Committee under the Ministry of Health of the Republic of Karelia and of Petrozavodsk State University (Minutes No. 47 of 01.11.2023).

Results. The frequency of the left ventricular diastolic dysfunction did not differ in  the  first and second groups of patients. Statistically significant differences were recorded in the average flow deceleration time for both early and late filling of the left ventricle in people who had and did not have COVID-19 infection. A change in the phase structure of the transmitral blood flow may be an early manifestation of intracardiac hemodynamic disorders in people who have recovered from COVID-19.

1. Tsyganova EV, Glukhoedova NV, Zhilenkova AS, Fedoseeva TI, Iushchuk EN, Smetneva NS. COVID-19 and features of cardiovascular involvement. Terapevticheskii arkhiv. 2021; 93(9): 1091-1099. (In Russ.). doi: 10.26442/00403660.2021.09.201036

2. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8(4): e21. doi: 10.1016/s2213-2600(20)30116-8

3. Yaroslavskaya EI, Krinochkin DV, Shirokov NE, Krinochkina IR, Gultyaeva EP, Garanina VD, et al. Echocardiographic characteristics of COVID-19 pneumonia survivors three months after hospital discharge. Russian Journal of Cardiology. 2021; 26(8): 4620. (In Russ.). doi: 10.15829/1560-4071-2021-4620

4. Skulstad H, Cosyns B, Popescu BA, Galderisi M, Salvo GD, Donal E, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020; 21(6): 592-598. doi: 10.1093/ehjci/jeaa072

5. Magoon R. Left-ventricular diastolic dysfunction in coronavirus disease: Opening Pandora’s box! Korean J Anesthesiol. 2021; 74(6): 557-558. doi: 10.4097/kja.21010

6. Dzemeshkevich SL, Motreva AP, Martyanova YuB, Kalmykova OV, Dombrovskaya AV, Nikituk TG, et al. COVID-19 infection and myocarditis after surgical left ventricle reconstruction in patient with hypertrophic cardiomyopathy. Clinical and Experimental Surgery. Petrovsky Journal. 2022; 10(2): 13-18. (In Russ.). doi: 10.33029/2308-1198-2022-10-2-13-18

7. Agricola E, Beneduce A, Esposito A, Ingallina G, Palumbo D, Palmisano A, et al. Heart and lung multimodality imaging in COVID-19. JACC Cardiovasc Imaging. 2020; 13(8): 1792-808. doi: 10.1016/j.jcmg.2020.05.017

8. Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017; 38(3): 143-153. doi: 10.1093/eurheartj/ehw149

9. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020; 35(6): 1302-1305. doi: 10.1111/jocs.14538

10. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265-1273. doi: 10.1001/jamacardio.2020.3557

11. Tian L, Duan F, Li X, Zhou C. Incidence, risk factors and prognostic effect of imaging left ventricular diastolic dysfunction in patients with COVID-19: Protocol for a systematic review. BMJ Open. 2022; 12: e059281. doi: 10.1136/bmjopen-2021-059281

12. Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et al. Spectrum of cardiac manifestations in COVID-19: A systematic echocardiographic study. Circulation. 2020; 142(4): 342-353. doi: 10.1161/CIRCULATIONAHA.120.047971

13. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5: 1265. doi: 10.1001/jamacardio.2020.3557

14. Slepukhina EA, Babaeva AR, Davydov SI, Kondryuchaya NS. Value of assessing left ventricular diastolic dysfunction in objectivization of heart failure diagnosis: Review of current international recommendations. Medical Alphabet. 2017; 2(31): 43-47. (In Russ.).

15. Szekely Yi, Lichter Ya, Taieb Ph, Banai A, Hochstadt A, Merdler I, et al. The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19) – A systematic echocardiographic study. Circulation. 2020; 142(4): 342-353. doi: 10.1161/CIRCULATIONAHA.120.047971

16. Rybakova MK, Mitkov VV, Baldin DG. Echocardiography from Rybakova. Moscow: Vidar; 2018. (In Russ.).

17. Mrikaev DV. Left ventricular diastolic dysfunction in patients with heart failure. Creative Cardiology, Russian Journal. 2017; 11(2): 145-158. (In Russ.). doi: 10.24022/1997-3187-2017-11-2-145-158

18. Kozlenok AA, Beresina AV, Bansheva AV, Bogomolova OV, Gizha IV, Didur MD, et al. Diastolic function as an early marker of disadaptation in athletes. Arterial Hypertension. 2006; 12(4): 319-324. (In Russ.). doi: 10.18705/1607-419X-2006-12-4-319-324

19. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 1-39.e14. doi: 10.1016/j.echo.2014.10.003

20. Tsvetkov VA, Krutikov ES, Chistyakova SI. Subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus. Problems of Endocrinology. 2020; 66(1): 56-63. (In Russ.). doi: 10.14341/probl12359

21. Dzhioeva ON. The importance of the diastolic dysfunction in the cardiovascular risk stratification of non-cardiac surgical intervention. Translational Medicine. 2018; 5(5): 18-25. (In Russ.). doi: 10.18705/2311-4495-2018-5-5-18-25

22. Vasiliev VA, Kondrichina SN, Solyanikova IN. Echocardiographic evaluation of diastolic dysfunctions and remodeling of the left ventricle in arterial hypertension. National Health. 2019; (4): 32-37. (In Russ.).

23. Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19): Interim guidelines; version 17. Moscow; 2022.

24. Miyoshi T, Addetia K, Citro R, Daimon M, Desale S, Fajardo PG, et al. Left ventricular diastolic function in healthy adult individuals: Results of the World Alliance Societies of Echocardiography Normal Values Study. J Am Soc Echocardiogr. 2020; 33(10): 1223-1233. doi: 10.1016/j.echo.2020.06.008

25. Bhatia HS, Bui QM, King K, DeMaria A, Daniels LB. Subclinical left ventricular dysfunction in COVID-19. Int J Cardiol Heart Vasc. 2021; 34: 100770. doi: 10.1016/j.ijcha.2021.100770

26. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009; 39(7): 618-625. doi: 10.1111/j.1365-2362.2009.02153. x

27. Panchenko DI, Kanorsky SG, Bystrov AO, Moisova DL, Gorodin VN, Ionov AYu. Clinical and echocardiographic changes in COVID-19 survivors 6 months after hospital discharge. Modern Problems of Science and Education. 2022; (2). (In Russ.). URL: https://science-education.ru/ru/article/view?id=31633 [date of access: 20.12.2022].